Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 25/gram
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Bortezomib |
|
|
Latin Name | Boronic acid,BortezoMib R;VELCADE(BORTEZOMIB) | ||
CAS NO | 179324-69-7 | ||
MF | C19H25BN4O4 | ||
MW | 384.24 | Density | 1.214 |
Assay | 99% | Form | White Powder |
Shelf life | 2 Years | Brand | Sonwu |
Bortezomib is the first proteasome inhibitor approved by the FDA for multiple myeloma. Reversible 26S proteasome inhibitor, a barrel-shaped multiprotein particle, found in the nucleus and cytoplasm of all eukaryotic cells. Targeting the ubiquitin-proteasome pathway.
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance